Patients with cardiac valve prosthesis: subsequent anaesthetic management for non-cardiac surgical procedures.
D000743:Anemia, Hemolytic / Q000209:etiology; D000768:Anesthesia, General; D000777:Anesthetics; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000209:etiology; D002302:Cardiac Output; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004696:Endocarditis / Q000209:etiology; D006331:Heart Diseases / Q000150:complications; D006333:Heart Failure / Q000517:prevention & control; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D006452:Hemoglobinometry; D006801:Humans; D008171:Lung Diseases / Q000150:complications; D011188:Potassium / Q000097:blood; D011229:Preanesthetic Medication; D011300:Preoperative Care; D011433:Propranolol / Q000627:therapeutic use; D013514:Surgical Procedures, Operative; D013923:Thromboembolism / Q000209:etiology
D000777:Anesthetics; D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D004071:Digitalis Glycosides; D004232:Diuretics; D011433:Propranolol; D011188:Potassium